Therapeutic Innovations in Mood and Anxiety Disorders Group

Group Lead

Professor Chee Ng; cng@unimelb.edu.au

Overview

The group based at the Melbourne Clinic is focussed on clinical trials for affective and anxiety disorders in the areas of psychopharmacology, neutraceuticals, psychological and lifestyle interventions, and brain stimulation.

Core Members

• Nathan Dowling
• Siu Ying Kwok
• Scott Blair West
• Niru Pitigala
• Richard Bonwick
• Anusha Bharal
• Lachlan Cribb

Select Current Projects

• The Candesartan Adjunctive Bipolar and Major Depression Trials: A double-blind, randomised, placebo-controlled trial
• Effects of Multicomponent Lifestyle Intervention for Depression: A randomized controlled trial and a process evaluation
• Exploring the effectiveness of the Bergen Inpatient Treatment Format for obsessive-compulsive disorder

Select Key Papers Antidepressant prescribing in the precision medicine era: a prescriber's primer on pharmacogenetic tools Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trial Lifestyle medicine for anxiety symptoms: A meta-analysis of randomized controlled trials Accelerated intermittent theta burst stimulation for major depressive disorder or bipolar depression: A systematic review and meta-analysis